以共聚维酮和交联聚维酮为载体的尼莫地平固体分散体物理稳定性和溶出行为研究

    Stability and Dissolution Study of Nimodipine Amorphous Solid Dispersion Using Copovidone and Crospovidone as Carriers

    • 摘要:
      目的  考察二元载体制剂处方中,难溶性药物尼莫地平(nimodipine,NMP)无定形固体分散体(amorphous solid dispersion,ASD)及其片剂的体外溶出特性与物理稳定性,并优化制剂处方。
      方法 以共聚维酮(copovidone,PVPVA)和交联聚维酮(crospovidone,PVPP)为载体,NMP为模型药,采用极端顶点混合设计处方,通过喷雾干燥技术制备ASD粉末。采用差示扫描量热法、傅里叶转换红外光谱法、扫描电镜、偏光显微镜、粉末X射线衍射实验考察制得ASD粉末理化性质和物理稳定性,采用原位光纤技术,考察ASD粉末及其片剂的体外溶出行为。
      结果 当NMP ASD载药量为20%,PVPVA含量为25%,PVPP含量为55%时,在1个月的加速条件下保持稳定。用喷雾干燥方法制备的ASD片剂与普通片剂比较具有更快的片剂崩解速度和更高的药物溶出速率。
      结论 单独使用PVPVA为载体的ASD片剂可能存在崩解时间长,药物溶出慢的问题;而单独使用PVPP为载体制得的ASD片剂能有效解决上述问题,但又存在无定形态药物物理稳定性较差的问题。通过2种聚合物载体组合制备的ASD片剂,既能达到良好的物理稳定性,又能实现快速崩解及释药。

       

      Abstract:
      OBJECTIVE  To investigate the dissolution and physical stability of the amorphous solid dispersion(ASD) containing a poorly soluble drug nimodipine(NMP). The binary carriers of copovidione and crospovidone were adopted to formulate the ASD and the ratio of copovidoine to crospovidione was optimized.
      METHODS  Copovidone(PVPVA) and crospovidone(PVPP) were selected as the polymeric carriers to prepare NMP solid dispersions by spray drying. Extreme vertices mix design was used to design formulations. Differential scanning calorimetry, fourier transform infrared spectroscopy, scanning electron microscope, polarization microscope and powder X-ray diffraction analysis were conducted to investigate the physicochemical properties and physical stability of ASDs. In-situ optical fiber technology was used to test in-vitro dissolution behavior of ASDs and their tablets.
      RESULTS  When the NMP ASD drug loading was 20%, the contents of PVPVA and PVPP was 25% and 55% respectively, ASD remained physically stable during accelerated stability test. The prepared ASD tablets exhibited shorter disintegration rate and faster drug dissolution rate.
      CONCLUSION  When copovidone alone is adopted as the ASD carrier, the ASD tablets have long disintegration time and slow drug dissolution; whereas if crospovidone is used as the carrier, the amorphous drug is not stable. The combination of copovidone and crospovidone as the ASD carrier can achieve better physical stability of amorphous drug, and the prepared ASD tablets show shorter disintegration time and faster drug dissolution.

       

    /

    返回文章
    返回